FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2081796762> ?p ?o ?g. }

• W2081796762 endingPage "1377" @default.
• W2081796762 startingPage "1377" @default.
• W2081796762 abstract "In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models Sarah Schleiferböck,1,2 Christian Scheurer,1,2 Masataka Ihara,3,4 Isamu Itoh,3,4 Ian Bathurst,5,† Jeremy N Burrows,5 Pascal Fantauzzi,5 Julie Lotharius,5 Susan A Charman,6 Julia Morizzi,6 David M Shackleford,6 Karen L White,6 Reto Brun,1,2 Sergio Wittlin1,21Swiss Tropical and Public Health Institute, Basel, 2University of Basel, Basel, Switzerland; 3Drug Discovery Science Research Center, Hoshi University, Shinagawa, Tokyo, Japan; 4Synstar Japan Co, Ltd, Odawara, Japan; 5Medicines for Malaria Venture, Geneva, Switzerland; 6Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Parkville, VIC, Australia †Ian Bathurst passed away on 26 June 2011Abstract: The objective of this work was to characterize the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activity profile of the recently discovered lead compound SSJ-183. The molecule showed in vitro a fast and strong inhibitory effect on growth of all P. falciparum blood stages, with a tendency to a more pronounced stage-specific action on ring forms at low concentrations. Furthermore, the compound appeared to be equally efficacious on drug-resistant and drug-sensitive parasite strains. In vivo, SSJ-183 showed a rapid onset of action, comparable to that seen for the antimalarial drug artesunate. SSJ-183 exhibited a half-life of about 10 hours and no significant differences in absorption or exposure between noninfected and infected mice. SSJ-183 appears to be a promising new lead compound with an attractive antimalarial profile.Keywords: antimalarial studies, cross-resistance, stage-specificity, Plasmodium falciparum" @default.
• W2081796762 created "2016-06-24" @default.
• W2081796762 creator A5009916074 @default.
• W2081796762 creator A5015175584 @default.
• W2081796762 creator A5020691910 @default.
• W2081796762 creator A5031843900 @default.
• W2081796762 creator A5033368239 @default.
• W2081796762 creator A5033723620 @default.
• W2081796762 creator A5045473085 @default.
• W2081796762 creator A5047305720 @default.
• W2081796762 creator A5050874457 @default.
• W2081796762 creator A5053189068 @default.
• W2081796762 creator A5054827010 @default.
• W2081796762 creator A5057759437 @default.
• W2081796762 creator A5067544706 @default.
• W2081796762 creator A5088068003 @default.
• W2081796762 date "2013-11-01" @default.
• W2081796762 modified "2023-09-26" @default.
• W2081796762 title "In vitro and in vivo characterization of the antimalarial lead compound SSJ-183 in Plasmodium models" @default.
• W2081796762 cites W183230364 @default.
• W2081796762 cites W2003127960 @default.
• W2081796762 cites W2019758371 @default.
• W2081796762 cites W2020251171 @default.
• W2081796762 cites W2056370907 @default.
• W2081796762 cites W2076029682 @default.
• W2081796762 cites W2076108308 @default.
• W2081796762 cites W2076183255 @default.
• W2081796762 cites W2087956351 @default.
• W2081796762 cites W2098923921 @default.
• W2081796762 cites W2138645583 @default.
• W2081796762 cites W2144874346 @default.
• W2081796762 cites W2146822159 @default.
• W2081796762 cites W2146883638 @default.
• W2081796762 cites W2148020902 @default.
• W2081796762 cites W2154313767 @default.
• W2081796762 cites W2166670458 @default.
• W2081796762 cites W2580216923 @default.
• W2081796762 doi "https://doi.org/10.2147/dddt.s51298" @default.
• W2081796762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3832383" @default.
• W2081796762 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24255594" @default.
• W2081796762 hasPublicationYear "2013" @default.
• W2081796762 type Work @default.
• W2081796762 sameAs 2081796762 @default.
• W2081796762 citedByCount "7" @default.
• W2081796762 countsByYear W20817967622015 @default.
• W2081796762 countsByYear W20817967622019 @default.
• W2081796762 countsByYear W20817967622020 @default.
• W2081796762 countsByYear W20817967622022 @default.
• W2081796762 countsByYear W20817967622023 @default.
• W2081796762 crossrefType "journal-article" @default.
• W2081796762 hasAuthorship W2081796762A5009916074 @default.
• W2081796762 hasAuthorship W2081796762A5015175584 @default.
• W2081796762 hasAuthorship W2081796762A5020691910 @default.
• W2081796762 hasAuthorship W2081796762A5031843900 @default.
• W2081796762 hasAuthorship W2081796762A5033368239 @default.
• W2081796762 hasAuthorship W2081796762A5033723620 @default.
• W2081796762 hasAuthorship W2081796762A5045473085 @default.
• W2081796762 hasAuthorship W2081796762A5047305720 @default.
• W2081796762 hasAuthorship W2081796762A5050874457 @default.
• W2081796762 hasAuthorship W2081796762A5053189068 @default.
• W2081796762 hasAuthorship W2081796762A5054827010 @default.
• W2081796762 hasAuthorship W2081796762A5057759437 @default.
• W2081796762 hasAuthorship W2081796762A5067544706 @default.
• W2081796762 hasAuthorship W2081796762A5088068003 @default.
• W2081796762 hasBestOaLocation W20817967621 @default.
• W2081796762 hasConcept C202751555 @default.
• W2081796762 hasConcept C203014093 @default.
• W2081796762 hasConcept C207001950 @default.
• W2081796762 hasConcept C2776120307 @default.
• W2081796762 hasConcept C2778048844 @default.
• W2081796762 hasConcept C2778059366 @default.
• W2081796762 hasConcept C2778371730 @default.
• W2081796762 hasConcept C2781160685 @default.
• W2081796762 hasConcept C54355233 @default.
• W2081796762 hasConcept C86803240 @default.
• W2081796762 hasConcept C98274493 @default.
• W2081796762 hasConceptScore W2081796762C202751555 @default.
• W2081796762 hasConceptScore W2081796762C203014093 @default.
• W2081796762 hasConceptScore W2081796762C207001950 @default.
• W2081796762 hasConceptScore W2081796762C2776120307 @default.
• W2081796762 hasConceptScore W2081796762C2778048844 @default.
• W2081796762 hasConceptScore W2081796762C2778059366 @default.
• W2081796762 hasConceptScore W2081796762C2778371730 @default.
• W2081796762 hasConceptScore W2081796762C2781160685 @default.
• W2081796762 hasConceptScore W2081796762C54355233 @default.
• W2081796762 hasConceptScore W2081796762C86803240 @default.
• W2081796762 hasConceptScore W2081796762C98274493 @default.
• W2081796762 hasLocation W20817967621 @default.
• W2081796762 hasLocation W20817967622 @default.
• W2081796762 hasLocation W20817967623 @default.
• W2081796762 hasOpenAccess W2081796762 @default.
• W2081796762 hasPrimaryLocation W20817967621 @default.
• W2081796762 hasRelatedWork W1609553144 @default.
• W2081796762 hasRelatedWork W2052130859 @default.
• W2081796762 hasRelatedWork W2063725332 @default.
• W2081796762 hasRelatedWork W2094082567 @default.
• W2081796762 hasRelatedWork W2104300146 @default.
• W2081796762 hasRelatedWork W2120453248 @default.

• next